Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
7.90
-0.38 (-4.53%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $261.18 million. The enterprise value is $109.45 million.

Market Cap 261.18M
Enterprise Value 109.45M

Important Dates

The next estimated earnings date is Thursday, November 21, 2024, after market close.

Earnings Date Nov 21, 2024
Ex-Dividend Date n/a

Share Statistics

LXEO has 33.06 million shares outstanding. The number of shares has increased by 1,114.55% in one year.

Shares Outstanding 33.06M
Shares Change (YoY) +1,114.55%
Shares Change (QoQ) +17.95%
Owned by Insiders (%) 4.43%
Owned by Institutions (%) 49.73%
Float 16.98M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.66
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.38, with a Debt / Equity ratio of 0.07.

Current Ratio 9.38
Quick Ratio 9.27
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -471.77

Financial Efficiency

Return on equity (ROE) is -74.83% and return on invested capital (ROIC) is -44.64%.

Return on Equity (ROE) -74.83%
Return on Assets (ROA) -39.93%
Return on Capital (ROIC) -44.64%
Revenue Per Employee n/a
Profits Per Employee -$1.33M
Employee Count 58
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 9.81
200-Day Moving Average 13.37
Relative Strength Index (RSI) 37.23
Average Volume (20 Days) 337,847

Short Selling Information

The latest short interest is 2.06 million, so 6.23% of the outstanding shares have been sold short.

Short Interest 2.06M
Short Previous Month 2.07M
Short % of Shares Out 6.23%
Short % of Float 12.13%
Short Ratio (days to cover) 5.46

Income Statement

Revenue n/a
Gross Profit -57.76M
Operating Income -82.09M
Pretax Income -69.42M
Net Income -77.22M
EBITDA -81.46M
EBIT -82.09M
Earnings Per Share (EPS) -$3.90
Full Income Statement

Balance Sheet

The company has $174.98 million in cash and $10.85 million in debt, giving a net cash position of $164.13 million or $4.96 per share.

Cash & Cash Equivalents 174.98M
Total Debt 10.85M
Net Cash 164.13M
Net Cash Per Share $4.96
Equity (Book Value) 164.95M
Book Value Per Share 4.99
Working Capital 158.27M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$62.95 million and capital expenditures -$474,000, giving a free cash flow of -$63.42 million.

Operating Cash Flow -62.95M
Capital Expenditures -474,000
Free Cash Flow -63.42M
FCF Per Share -$1.92
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,114.55%
Shareholder Yield -1,114.55%
Earnings Yield -28.22%
FCF Yield -23.18%

Analyst Forecast

The average price target for LXEO is $22.14, which is 180.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target $22.14
Price Target Difference 180.25%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -26.85%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2